A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide (opens ClinicalTrials.gov)
- Sponsor
- Eli Lilly and Company
- Enrolment
- 200
- Started
- 2025-03-28
- Last update
- 2026-11-04
Conditions: Type 2 Diabetes
Interventions: LY3457263, Placebo